About 86 Trademarks found for “trel*”
Filters
Also try searching for:
*rel
Mark | Details | Status | Class/Description | |
---|---|---|---|---|
TRELZAF VIIV HEALTHCARE UK LIMITED 1531199 10 Jun 2011 | ABANDONED SECTION 40(3) on 2 Jul 2015 | Anti-viral pharmaceutical preparations and substances. Class 005 Class 005 Pharmaceutical Products Anti-viral pharmaceutical preparations and substances. | ||
TRELLIS Vertiv IT Systems, Inc. 1526976 9 May 2011 | REGISTERED on 8 Jul 2019 | Data center infrastructure management computer software, namely softwa... Class 007 Class 007 Machinery Products Data center infrastructure management computer software, namely software to design, monitor and manage components of an IT data center; physical asset tracking computer software, namely software to track inventory of components of an IT data center; impact and utilization analysis computer software, namely software to monitor and optimize data center and computer room equipment utility and operation; inventory and planning reporting computer software, namely software to monitor IT data center and computer room inventory and inventory planning; asset automation and monitoring computer software, namely software to automate and monitor components of IT data centers and computer rooms; visual modeling computer software, namely software that visually models structures and components of IT data centers and computer rooms; computer and telecommunications hardware, namely, computers, computer hardware and digital signal process control hardware; computer firmware for business process management, for use in operating control systems, for alarming, controlling, reading and managing event log information and notifications and accessing data center and computer room equipment; computer firmware for remote monitoring of hardware; computer peripherals, namely, network switches and computer switches; automatic transfer switches; power transfer switches; data transfer switches; static transfer switches; computer power supplies; integrated power supplies; uninterruptible power supplies (UPS); cooling systems, namely CPU coolers; voltage surge suppressors for IT data center and computer room apparatuses and equipment; storage and mounting racks for IT data center and computer room apparatuses and equipment; computer and communications servers for IT data centers and computer rooms; blade servers for IT data centers and computer rooms; virtual server software; software for monitoring virtual servers, providing virtual application servers, web servers, file servers, co-location servers, load balancing servers, redundancy servers, media servers and database servers of variable capacity to third-party computing and data storage facilities; network access server hardware, namely server racks; accumulators [batteries], namely, electric batteries and renewable battery systems for providing backup power to network servers and electronic equipment and data center and computer room equipment and devices, namely, computer hardware, computer peripheral devices; power distribution units (PDUs); controllers, namely power controllers and electrical controllers; electrical fire pump controllers; control cabinets for IT data centers and computer rooms; control cabinets for computer hardware and telecommunications equipment; electric distribution consoles; LCD consoles; information management systems comprised of computer hardware and computer system utilities, namely, computer management software for centralized remote accessing and controlling computer systems, serial-based devices, servers, namely, application servers, email servers, database servers, internet servers and e-communication servers, and power distribution products, namely, uninterruptible power supplies (UPS) and power strips; integrated circuit modules, computer software modules for monitoring electric current and electric signals; application modules for monitoring electric current and electric signals in data center and computer room equipment and facilities; computer hardware modules for monitoring electric current and electric signals; power regulators; voltage regulators; cooling systems for IT data centers and computer rooms; fan controls, namely electronic controllers for CPU fans; panel doors for control cabinets for computer hardware and telecommunications equipment; computer monitors; voltage surge protectors; electric surge protectors; data center information management systems comprising computers, computer hardware and software to control, monitor and manage IT data center and computer room infrastructure equipment, HVAC/R systems for use with IT data centers and computer rooms, computer server hardware and computer software for operating IT data center and computer room equipment, firmware for operating IT data center and computer room equipment, computer network switches, transfer switches, surge suppressors, backup power systems, namely, power generators, power converters, uninterruptible power supplies (UPS), cabinets for IT data centers and computer rooms, racks for computer hardware and telecommunications equipment for IT data centers and computer rooms, electric batteries and renewable battery systems for providing backup power to network servers and electronic equipment and data center and computer room equipment and devices, namely, computer hardware, computer peripheral devices, electronic controllers, fire pump controllers, power distribution units, LCD consoles; HVAC/R; environmental control devices, namely cooling systems to control and regulate temperature and humidity of IT data centers and computer rooms; refrigeration condensers for IT data centers and computer rooms; compressors, namely, compressors for industrial machinery, electric compressors and refrigerant compressors for IT data centers and computer rooms; dry coolers for IT data centers and computer rooms; air conditioners Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Distributorships in the field of computer software; online monitoring using computer software to monitor infrastructure and data center systems and equipment, capturing the data and providing documentation and analysis of the data to others for business purposes, business consultation in the field of telecommunications expense management, operation and administration of telecommunications systems and networks for others, data processing services; maintenance and repair of infrastructure and data center systems and equipment; telecommunications consultation in the nature of technical consulting in the field of audio, text and visual data transmission and communication; consultation in the field of telecommunications technology, namely, transmission of voice, data, graphics, images, audio and video by means of electronic, optical, telephony and broadband telecommunication networks, wireless communication networks and the internet; consultation in the field of electronic, optical, telephony and broadband telecommunication systems and networks; telecommunication services, namely, providing multiple-user access to a global computer network; transfer of data of others by wired and wireless telecommunication systems and networks, namely, electronic, optical, telephony and broadband and the internet; transmission of data of others by wired and wireless telecommunication systems and networks and the internet; consulting in the field of maintenance and repair of telecommunications network, hardware and equipment; maintenance and repair of telecommunications network hardware and equipment; data center performance optimization, namely, monitoring, assessment and management of computer network infrastructure; technical support services, namely troubleshooting in the nature of diagnosing computer hardware and software problems and monitoring telecommunications equipment and computer equipment, namely infrastructure monitoring measurement and management; emergency monitoring, management and measurement, namely, metering and monitoring electric power; data center monitoring and management, namely monitoring of network and data center systems; computer services, namely website monitoring of others to improve scalability and performance of websites for others; computer services, namely monitoring the computer systems of others for technical purposes and providing back-up computer programs and facilities; spatial mapping; consulting services in the field of data center infrastructure management; business consultation in the field of telecommunications technology, namely, transmission of voice, data, graphics, images, audio and video by means of electronic, optical, telephony and broadband telecommunication networks and wireless communication networks and the internet; consultation in the field of electronic, optical, telephony and broadband telecommunication systems and networks; business consultation in the field of IT equipment, namely, hardware, software and devices for data center design and management, enterprise storage, system virtualization, business continuity planning, disaster recovery planning, security and process optimization; consultation and physical maintenance of IT equipment and facilities, namely, data centers and computer rooms; consultation in the field of telecommunication technology, namely, transmission of voice, data, graphics, images, audio and video by means of electronic, optical, telephony and broadband telecommunication networks, wireless communication networks and the internet; computer consultation, namely, consulting services in the field of design, selection, implementation and use of computer hardware and software systems, computer peripherals, computer networks; computer software consultation; consultation in the field of environmental engineering; information technology consultation; consulting in the field of telecommunications technology; computer services, namely, software as a service featuring software for use in data center infrastructure management, IT equipment and physical infrastructure management; providing use of on-line non-downloadable data center infrastructure management software, physical asset tracking software, impact and utilization analysis software, inventory and planning reporting software, automation and monitoring software and visual modeling software; computer services, namely, providing technical assistance in the field of implementation, customization, maintenance, operation and management of computer hardware, software, peripherals and networks ... Class 011 Environmental Control Instrument Products lighting heating cooling cooking Class 035 Advertising, Business & Retail Services Class 037 Construction and Repair Services Class 038 Communications Services Class 042 Computer & Software Services & Scientific Services | ||
TREL TREL SYSTEMS AG 1458733 12 Nov 2009 | ABANDONED SECTION 36 on 8 Jul 2011 | (a) Building materials (non-metallic), in particular structural elemen... Class 019 Class 019 Non-Metallic Building Material Products (a) Building materials (non-metallic), in particular structural elements, construction panels and dry construction panels; structural elements and construction panels made of wood, plasterboard, gypsum fibreboards, mineral fibres and gypsum; non-metallic structural elements for producing ceilings, walls, separating walls, partition walls and facing walls; wall and separating wall elements in combination with furniture components such as shelves and cupboards; (b) Furniture, shelves, cupboards; wall and separating wall elements in combination with furniture components such as shelves and cupboards. Class 020 Class 020 Furniture Products (a) Construction engineering; management of construction work; interior work; pargetting, plasterwork, rendering, masonry, paintwork and carpentry; constructing and mounting wall, partition wall, facing wall and separating wall elements in combination with furniture components such as shelves and cupboards; (b) Constructional advice; services of an interior designer; services of a structural engineer; technical advice in conjunction with the construction and mounting of wall, partition wall, facing wall and separating wall elements in combination with furniture components such as shelves and cupboards. ... Class 037 Construction and Repair Services Class 042 Computer & Software Services & Scientific Services | ||
TRELEGY GLAXO GROUP LIMITED 1436250 28 Apr 2009 | ABANDONED SECTION 40(3) on 18 Nov 2015 | Pharmaceutical preparations for use as anti-infectives; Pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans. | ||
TRELROSE VIIV HEALTHCARE UK LIMITED 1436253 28 Apr 2009 | WITHDRAWN BY OWNER on 18 Sept 2015 | Pharmaceutical preparations for use as anti-infectives; Pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans. | ||
TRELTAVE GLAXO GROUP LIMITED 1436248 28 Apr 2009 | ABANDONED SECTION 40(3) on 18 Nov 2015 | Pharmaceutical preparations for use as anti-infectives; Pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans. | ||
TRELZAPH GLAXO GROUP LIMITED 1436255 28 Apr 2009 | WITHDRAWN BY OWNER on 16 Feb 2012 | Pharmaceutical preparations for use as anti-infectives; Pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans. | ||
TRELBO GLAXO GROUP LIMITED 1400032 17 Jun 2008 | ABANDONED SECTION 40(3) on 4 Jan 2012 | Pharmaceutical preparations for use as anti-infectives; Pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans. | ||
TRELAVUE VIIV HEALTHCARE UK LIMITED 1400029 17 Jun 2008 | ABANDONED SECTION 40(3) on 9 Feb 2015 | Pharmaceutical preparations for use as anti-infectives; Pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans. | ||
TRELFREE OTSUKA PHARMACEUTICAL CO. LTD. 1349281 29 May 2007 | ABANDONED SECTION 40(3) on 24 Sept 2010 | Pharmaceutical preparations for the treatment of the central nervous s... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of the central nervous system, namely stimulants, antipyretic analgesics, anti-epileptics, analeptics, hypnotic sedatives, general anesthetics and anti-motionsickness agents; pharmaceutical preparations for the treatment of the peripheral nervous system, namely local anesthetics, skeletal muscle relaxants, anhidrotics, autonomics, antispasmodics and diaphoretics; pharmaceutical preparations for the treatment of sensory organs, namely antiglaucoma and anti-intraocular hypertension drugs; pharmaceutical preparations for the treatment of respiratory organs, namely respiratory stimulants, anti-cough drops and anti-tussive expectorants; pharmaceutical preparations for the treatment of digestive organs, namely gastrointestinal cleaning agents, clysters, evacuants [purgatives], stomachics and digestives, mouth cavity cleansers for medical purposes, breath refreshers, emetics, antacids, intestinal regulators, antiemetics, castor oil for medical purposes, tooth prophylactics, cholagogues; pharmaceutical preparations for the treatment of cardiovascular system, namely cardiotonics, antihypertensives, vasoconstrictors, capillary stabilizers, cerebral haemorrhage prophylactics agents, antiarrhythmic agents and diuretics; pharmaceutical preparations for the treatment of dermatological disorders, and for the treatment of cancer (chemotherapeutic agents); pharmaceutical preparations for the activation of cellular function, for suppression of tumors; allergy medications; hormones for human use; vitamins; antibiotics; pharmaceutical preparations, namely, parenteral solutions used to supply amino acids in the following cases: hypoproteinemia, malnutrition and pre- and/or post-operative states; oral nutritional supplements and/or tube feeding formula for the nutritional support of diabetic patients; pharmaceutical preparations containing a-interferon for the treatment of viremia caused by viral hepatitis type B and C and treatment of hypernephroma; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of Hepatitis C; pharmaceutical drugs and medicines, namely, contrast medium for digestive organs; medical diagnostic reagent for measuring gas content in exhaled breath to determine existence of micro-organism in human digestive organs and medical reagents for diseases in digestive organs; diagnostic medical, chemical and pharmaceutical preparations for detecting Helicobacter-pylori for use in breath tests; pharmaceutical preparations for the eradication of helicobacter-pylori; blood and body fluid agents. |
on 2 Jul 2015
VIIV HEALTHCARE UK LIMITED
1531199 · 10 Jun 2011
005
Class 005
Pharmaceutical Products
Anti-viral pharmaceutical preparations and substances.
Anti-viral pharmaceutical preparations and substances.
on 8 Jul 2019
Vertiv IT Systems, Inc.
1526976 · 9 May 2011
007
Class 007
Machinery Products
Data center infrastructure management computer software, namely software to design, monitor and manage components of an IT data center; physical asset tracking computer software, namely software to track inventory of components of an IT data center; impact and utilization analysis computer software, namely software to monitor and optimize data center and computer room equipment utility and operation; inventory and planning reporting computer software, namely software to monitor IT data center and computer room inventory and inventory planning; asset automation and monitoring computer software, namely software to automate and monitor components of IT data centers and computer rooms; visual modeling computer software, namely software that visually models structures and components of IT data centers and computer rooms; computer and telecommunications hardware, namely, computers, computer hardware and digital signal process control hardware; computer firmware for business process management, for use in operating control systems, for alarming, controlling, reading and managing event log information and notifications and accessing data center and computer room equipment; computer firmware for remote monitoring of hardware; computer peripherals, namely, network switches and computer switches; automatic transfer switches; power transfer switches; data transfer switches; static transfer switches; computer power supplies; integrated power supplies; uninterruptible power supplies (UPS); cooling systems, namely CPU coolers; voltage surge suppressors for IT data center and computer room apparatuses and equipment; storage and mounting racks for IT data center and computer room apparatuses and equipment; computer and communications servers for IT data centers and computer rooms; blade servers for IT data centers and computer rooms; virtual server software; software for monitoring virtual servers, providing virtual application servers, web servers, file servers, co-location servers, load balancing servers, redundancy servers, media servers and database servers of variable capacity to third-party computing and data storage facilities; network access server hardware, namely server racks; accumulators [batteries], namely, electric batteries and renewable battery systems for providing backup power to network servers and electronic equipment and data center and computer room equipment and devices, namely, computer hardware, computer peripheral devices; power distribution units (PDUs); controllers, namely power controllers and electrical controllers; electrical fire pump controllers; control cabinets for IT data centers and computer rooms; control cabinets for computer hardware and telecommunications equipment; electric distribution consoles; LCD consoles; information management systems comprised of computer hardware and computer system utilities, namely, computer management software for centralized remote accessing and controlling computer systems, serial-based devices, servers, namely, application servers, email servers, database servers, internet servers and e-communication servers, and power distribution products, namely, uninterruptible power supplies (UPS) and power strips; integrated circuit modules, computer software modules for monitoring electric current and electric signals; application modules for monitoring electric current and electric signals in data center and computer room equipment and facilities; computer hardware modules for monitoring electric current and electric signals; power regulators; voltage regulators; cooling systems for IT data centers and computer rooms; fan controls, namely electronic controllers for CPU fans; panel doors for control cabinets for computer hardware and telecommunications equipment; computer monitors; voltage surge protectors; electric surge protectors; data center information management systems comprising computers, computer hardware and software to control, monitor and manage IT data center and computer room infrastructure equipment, HVAC/R systems for use with IT data centers and computer rooms, computer server hardware and computer software for operating IT data center and computer room equipment, firmware for operating IT data center and computer room equipment, computer network switches, transfer switches, surge suppressors, backup power systems, namely, power generators, power converters, uninterruptible power supplies (UPS), cabinets for IT data centers and computer rooms, racks for computer hardware and telecommunications equipment for IT data centers and computer rooms, electric batteries and renewable battery systems for providing backup power to network servers and electronic equipment and data center and computer room equipment and devices, namely, computer hardware, computer peripheral devices, electronic controllers, fire pump controllers, power distribution units, LCD consoles; HVAC/R; environmental control devices, namely cooling systems to control and regulate temperature and humidity of IT data centers and computer rooms; refrigeration condensers for IT data centers and computer rooms; compressors, namely, compressors for industrial machinery, electric compressors and refrigerant compressors for IT data centers and computer rooms; dry coolers for IT data centers and computer rooms; air conditioners
009
Class 009
Computer & Software Products & Electrical & Scientific Products
Distributorships in the field of computer software; online monitoring using computer software to monitor infrastructure and data center systems and equipment, capturing the data and providing documentation and analysis of the data to others for business purposes, business consultation in the field of telecommunications expense management, operation and administration of telecommunications systems and networks for others, data processing services; maintenance and repair of infrastructure and data center systems and equipment; telecommunications consultation in the nature of technical consulting in the field of audio, text and visual data transmission and communication; consultation in the field of telecommunications technology, namely, transmission of voice, data, graphics, images, audio and video by means of electronic, optical, telephony and broadband telecommunication networks, wireless communication networks and the internet; consultation in the field of electronic, optical, telephony and broadband telecommunication systems and networks; telecommunication services, namely, providing multiple-user access to a global computer network; transfer of data of others by wired and wireless telecommunication systems and networks, namely, electronic, optical, telephony and broadband and the internet; transmission of data of others by wired and wireless telecommunication systems and networks and the internet; consulting in the field of maintenance and repair of telecommunications network, hardware and equipment; maintenance and repair of telecommunications network hardware and equipment; data center performance optimization, namely, monitoring, assessment and management of computer network infrastructure; technical support services, namely troubleshooting in the nature of diagnosing computer hardware and software problems and monitoring telecommunications equipment and computer equipment, namely infrastructure monitoring measurement and management; emergency monitoring, management and measurement, namely, metering and monitoring electric power; data center monitoring and management, namely monitoring of network and data center systems; computer services, namely website monitoring of others to improve scalability and performance of websites for others; computer services, namely monitoring the computer systems of others for technical purposes and providing back-up computer programs and facilities; spatial mapping; consulting services in the field of data center infrastructure management; business consultation in the field of telecommunications technology, namely, transmission of voice, data, graphics, images, audio and video by means of electronic, optical, telephony and broadband telecommunication networks and wireless communication networks and the internet; consultation in the field of electronic, optical, telephony and broadband telecommunication systems and networks; business consultation in the field of IT equipment, namely, hardware, software and devices for data center design and management, enterprise storage, system virtualization, business continuity planning, disaster recovery planning, security and process optimization; consultation and physical maintenance of IT equipment and facilities, namely, data centers and computer rooms; consultation in the field of telecommunication technology, namely, transmission of voice, data, graphics, images, audio and video by means of electronic, optical, telephony and broadband telecommunication networks, wireless communication networks and the internet; computer consultation, namely, consulting services in the field of design, selection, implementation and use of computer hardware and software systems, computer peripherals, computer networks; computer software consultation; consultation in the field of environmental engineering; information technology consultation; consulting in the field of telecommunications technology; computer services, namely, software as a service featuring software for use in data center infrastructure management, IT equipment and physical infrastructure management; providing use of on-line non-downloadable data center infrastructure management software, physical asset tracking software, impact and utilization analysis software, inventory and planning reporting software, automation and monitoring software and visual modeling software; computer services, namely, providing technical assistance in the field of implementation, customization, maintenance, operation and management of computer hardware, software, peripherals and networks
...
Class 011
Environmental Control Instrument Products lighting heating cooling cooking
Class 035
Advertising, Business & Retail Services
Class 037
Construction and Repair Services
Class 038
Communications Services
Class 042
Computer & Software Services & Scientific Services
Data center infrastructure management computer software, namely softwa...
on 8 Jul 2011
TREL SYSTEMS AG
1458733 · 12 Nov 2009
019
Class 019
Non-Metallic Building Material Products
(a) Building materials (non-metallic), in particular structural elements, construction panels and dry construction panels; structural elements and construction panels made of wood, plasterboard, gypsum fibreboards, mineral fibres and gypsum; non-metallic structural elements for producing ceilings, walls, separating walls, partition walls and facing walls; wall and separating wall elements in combination with furniture components such as shelves and cupboards; (b) Furniture, shelves, cupboards; wall and separating wall elements in combination with furniture components such as shelves and cupboards.
020
Class 020
Furniture Products
(a) Construction engineering; management of construction work; interior work; pargetting, plasterwork, rendering, masonry, paintwork and carpentry; constructing and mounting wall, partition wall, facing wall and separating wall elements in combination with furniture components such as shelves and cupboards; (b) Constructional advice; services of an interior designer; services of a structural engineer; technical advice in conjunction with the construction and mounting of wall, partition wall, facing wall and separating wall elements in combination with furniture components such as shelves and cupboards.
...
Class 037
Construction and Repair Services
Class 042
Computer & Software Services & Scientific Services
(a) Building materials (non-metallic), in particular structural elemen...
on 18 Nov 2015
GLAXO GROUP LIMITED
1436250 · 28 Apr 2009
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans.
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical...
on 18 Sept 2015
VIIV HEALTHCARE UK LIMITED
1436253 · 28 Apr 2009
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans.
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical...
on 18 Nov 2015
GLAXO GROUP LIMITED
1436248 · 28 Apr 2009
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans.
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical...
on 16 Feb 2012
GLAXO GROUP LIMITED
1436255 · 28 Apr 2009
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans.
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical...
on 4 Jan 2012
GLAXO GROUP LIMITED
1400032 · 17 Jun 2008
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans.
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical...
on 9 Feb 2015
VIIV HEALTHCARE UK LIMITED
1400029 · 17 Jun 2008
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment or prevention of cardiovascular, cardiopulmonary, cardio-renal, and renal diseases; Pharmaceutical preparations for the prevention and treatment of oncological diseases; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and their symptoms; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely: central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of Parkinson's Disease, Alzheimers disease and dementia; Pharmaceutical preparations for the treatment of insomnia, restless leg, fibromyalgia, epilepsy, migraine, pain, stroke and multiple sclerosis; Pharmaceutical preparations for the treatment of pain namely neuropathic pain, inflammatory-related pain and fibromyalgia; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, and infections in or of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders, and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely pre-term labour, hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders, and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and females sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder, and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases, reproductive health and fertility, contraception, bladder and continence disorders, prostate diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, pre-term labour, pre-eclampsia, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone; Pharmaceutical preparations for the treatment of infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease; Pharmaceutical preparations for the treatment of PMDD/PMS, dysmenorrheal, male hypogonadism, and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of male pattern baldness; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of obesity or to aid in weight loss or weight management; Pharmaceutical preparations for the treatment of sepsis; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely, prophylactic and therapeutic vaccines for humans.
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical...
on 24 Sept 2010
OTSUKA PHARMACEUTICAL CO. LTD.
1349281 · 29 May 2007
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of the central nervous system, namely stimulants, antipyretic analgesics, anti-epileptics, analeptics, hypnotic sedatives, general anesthetics and anti-motionsickness agents; pharmaceutical preparations for the treatment of the peripheral nervous system, namely local anesthetics, skeletal muscle relaxants, anhidrotics, autonomics, antispasmodics and diaphoretics; pharmaceutical preparations for the treatment of sensory organs, namely antiglaucoma and anti-intraocular hypertension drugs; pharmaceutical preparations for the treatment of respiratory organs, namely respiratory stimulants, anti-cough drops and anti-tussive expectorants; pharmaceutical preparations for the treatment of digestive organs, namely gastrointestinal cleaning agents, clysters, evacuants [purgatives], stomachics and digestives, mouth cavity cleansers for medical purposes, breath refreshers, emetics, antacids, intestinal regulators, antiemetics, castor oil for medical purposes, tooth prophylactics, cholagogues; pharmaceutical preparations for the treatment of cardiovascular system, namely cardiotonics, antihypertensives, vasoconstrictors, capillary stabilizers, cerebral haemorrhage prophylactics agents, antiarrhythmic agents and diuretics; pharmaceutical preparations for the treatment of dermatological disorders, and for the treatment of cancer (chemotherapeutic agents); pharmaceutical preparations for the activation of cellular function, for suppression of tumors; allergy medications; hormones for human use; vitamins; antibiotics; pharmaceutical preparations, namely, parenteral solutions used to supply amino acids in the following cases: hypoproteinemia, malnutrition and pre- and/or post-operative states; oral nutritional supplements and/or tube feeding formula for the nutritional support of diabetic patients; pharmaceutical preparations containing a-interferon for the treatment of viremia caused by viral hepatitis type B and C and treatment of hypernephroma; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of Hepatitis C; pharmaceutical drugs and medicines, namely, contrast medium for digestive organs; medical diagnostic reagent for measuring gas content in exhaled breath to determine existence of micro-organism in human digestive organs and medical reagents for diseases in digestive organs; diagnostic medical, chemical and pharmaceutical preparations for detecting Helicobacter-pylori for use in breath tests; pharmaceutical preparations for the eradication of helicobacter-pylori; blood and body fluid agents.
Pharmaceutical preparations for the treatment of the central nervous s...
Owners
Glaxo group limited (7)
International paints (canada) limited (5)
Trelleborg ab (4)
Viiv healthcare uk limited (4)
Metso outotec finland oy (3)
Trello, inc., a legal entity (3)
Allergan sales llc (2)
Lewis-goetz and company inc. (a pennsylvania corporation) (2)
Musarubra us llc (2)
Scripture union service limited (2)
Categories
Class 5 (24)
Class 9 (19)
Class 42 (18)
Class 12 (10)
Class 35 (9)
Class 7 (8)
Class 19 (8)
Class 17 (7)
Class 38 (6)
Class 41 (6)
Class 2 (5)
Class 10 (5)
Class 11 (5)
Class 16 (4)
Class 37 (4)
Class 44 (4)
Class 6 (3)
Class 39 (3)
Class 3 (2)
Class 20 (2)
Class 27 (2)
Class 45 (2)
Class 21 (1)
Class 24 (1)
Class 29 (1)
Class 32 (1)
Class 33 (1)
Class 36 (1)
Class 43 (1)
Correspondents
Smart & biggar lp (19)
Gowling wlg (canada) llp (13)
Borden ladner gervais llp (8)
Robic agence pi s.E.C./ robic ip agency lp (6)
Aventum ip law llp (3)
Riches, mckenzie & herbert llp (3)
Smart & biggar ip agency co. (3)
Blake, cassels & graydon llp (2)
Cassels brock & blackwell llp (2)
Apply for Trademark
Select countries to protect your logo Trademark
Trademark Name
Country Selected
Canada
C$500/ 1 class + gov fee
United States
C$137/ 1 class + gov fee
Canada
C$500/ 1 class + gov fee
Mexico
C$691/ 1 class + gov fee
European Union
C$969/ 1 class + gov fee
China
C$691/ 1 class + gov fee
South Korea
C$967/ 1 class + gov fee
Japan
C$1,106/ 1 class + gov fee
India
C$137/ 1 class + gov fee
United Kingdom
C$691/ 1 class + gov fee
Australia
C$414/ 1 class + gov fee
Israel
C$967/ 1 class + gov fee
United Arab Emirates
C$967/ 1 class + gov fee
New Zealand
C$967/ 1 class + gov fee
Brazil
C$691/ 1 class + gov fee
Taiwan
C$1,106/ 1 class + gov fee
Ukraine
C$1,106/ 1 class + gov fee
Indonesia
C$967/ 1 class + gov fee
South Africa
C$691/ 1 class + gov fee
Singapore
C$1,106/ 1 class + gov fee
Saudi Arabia
C$1,106/ 1 class + gov fee
Afghanistan
C$1,106/ 1 class + gov fee
Algeria
C$1,106/ 1 class + gov fee
Argentina
C$552/ 1 class + gov fee
Austria
C$1,244/ 1 class + gov fee
Bahrain
C$967/ 1 class + gov fee
Bangladesh
C$829/ 1 class + gov fee
Benelux
C$1,382/ 1 class + gov fee
Bhutan
C$1,244/ 1 class + gov fee
Bolivia
C$1,106/ 1 class + gov fee
Botswana
C$1,797/ 1 class + gov fee
British Virgin Islands
C$1,659/ 1 class + gov fee
Bulgaria
C$1,106/ 1 class + gov fee
Cambodia
C$1,106/ 1 class + gov fee
Chile
C$691/ 1 class + gov fee
Colombia
C$967/ 1 class + gov fee
Congo
C$1,659/ 1 class + gov fee
Costa Rica
C$1,244/ 1 class + gov fee
Croatia
C$1,244/ 1 class + gov fee
Cyprus
C$1,382/ 1 class + gov fee
Czech Republic
C$1,244/ 1 class + gov fee
Denmark
C$1,106/ 1 class + gov fee
Curacao
C$1,659/ 1 class + gov fee
Macau
C$967/ 1 class + gov fee
Dominican Republic
C$1,244/ 1 class + gov fee
Aruba
C$1,659/ 1 class + gov fee
Greenland
C$1,106/ 1 class + gov fee
Ecuador
C$1,106/ 1 class + gov fee
Egypt
C$967/ 1 class + gov fee
El Salvador
C$1,106/ 1 class + gov fee
Ethiopia
C$1,521/ 1 class + gov fee
France
C$1,244/ 1 class + gov fee
Gaza
C$1,106/ 1 class + gov fee
Germany
C$1,244/ 1 class + gov fee
Greece
C$1,106/ 1 class + gov fee
Guatemala
C$1,244/ 1 class + gov fee
Haiti
C$1,244/ 1 class + gov fee
Honduras
C$1,244/ 1 class + gov fee
Hong Kong (SAR)
C$1,244/ 1 class + gov fee
Hungary
C$1,521/ 1 class + gov fee
Iraq
C$2,074/ 1 class + gov fee
Italy
C$1,244/ 1 class + gov fee
Jordan
C$1,106/ 1 class + gov fee
Kazakhstan
C$1,106/ 1 class + gov fee
Kenya
C$1,244/ 1 class + gov fee
Kuwait
C$1,106/ 1 class + gov fee
Laos
C$967/ 1 class + gov fee
Lebanon
C$1,382/ 1 class + gov fee
Lesotho
C$1,659/ 1 class + gov fee
Libya
C$1,244/ 1 class + gov fee
Madrid Protocol (WIPO)
C$2,766/ 1 class + gov fee
Malawi
C$1,521/ 1 class + gov fee
Malaysia
C$967/ 1 class + gov fee
Maldives
C$1,382/ 1 class + gov fee
Morocco
C$1,382/ 1 class + gov fee
Mozambique
C$1,244/ 1 class + gov fee
Myanmar
C$1,106/ 1 class + gov fee
Namibia
C$1,106/ 1 class + gov fee
Nepal
C$967/ 1 class + gov fee
Nicaragua
C$1,244/ 1 class + gov fee
Norway
C$1,244/ 1 class + gov fee
Oman
C$1,521/ 1 class + gov fee
Pakistan
C$1,106/ 1 class + gov fee
Panama
C$1,244/ 1 class + gov fee
Paraguay
C$1,244/ 1 class + gov fee
Peru
C$1,106/ 1 class + gov fee
Philippines
C$1,244/ 1 class + gov fee
Poland
C$691/ 1 class + gov fee
Portugal
C$1,244/ 1 class + gov fee
Puerto Rico
C$1,244/ 1 class + gov fee
Qatar
C$1,106/ 1 class + gov fee
Romania
C$1,244/ 1 class + gov fee
Serbia
C$1,244/ 1 class + gov fee
Slovakia
C$1,244/ 1 class + gov fee
Spain
C$1,244/ 1 class + gov fee
Sri Lanka
C$967/ 1 class + gov fee
Swaziland
C$1,797/ 1 class + gov fee
Sweden
C$1,106/ 1 class + gov fee
Switzerland
C$1,244/ 1 class + gov fee
Thailand
C$1,106/ 1 class + gov fee
Tunisia
C$1,244/ 1 class + gov fee
Turkey
C$1,106/ 1 class + gov fee
Uganda
C$967/ 1 class + gov fee
United Republic of Tanzania
C$967/ 1 class + gov fee
Uruguay
C$1,106/ 1 class + gov fee
Venezuela
C$1,244/ 1 class + gov fee
Vietnam
C$1,106/ 1 class + gov fee
West Bank, Palestine
C$1,106/ 1 class + gov fee
Yemen
C$2,351/ 1 class + gov fee
Albania
C$1,244/ 1 class + gov fee
Andorra
C$1,244/ 1 class + gov fee
Angola
C$1,797/ 1 class + gov fee
Antigua and Barbuda
C$1,659/ 1 class + gov fee
Armenia
C$1,106/ 1 class + gov fee
Azerbaijan
C$1,106/ 1 class + gov fee
Bahamas
C$1,936/ 1 class + gov fee
Barbados
C$1,797/ 1 class + gov fee
Belgium
C$1,382/ 1 class + gov fee
Belize
C$1,797/ 1 class + gov fee
Benin
C$1,106/ 1 class + gov fee
Bosnia and Herzegovina
C$1,382/ 1 class + gov fee
Brunei
C$1,797/ 1 class + gov fee
Burkina Faso
C$1,106/ 1 class + gov fee
Burundi
C$1,659/ 1 class + gov fee
Cabo Verde
C$1,244/ 1 class + gov fee
Cameroon
C$1,106/ 1 class + gov fee
Central African Republic (CAR)
C$1,106/ 1 class + gov fee
Chad
C$1,106/ 1 class + gov fee
Comoros
C$1,106/ 1 class + gov fee
Cote d'Ivoire
C$1,106/ 1 class + gov fee
Czechia
C$1,382/ 1 class + gov fee
Djibouti
C$1,659/ 1 class + gov fee
Dominica
C$1,797/ 1 class + gov fee
Equatorial Guinea
C$1,106/ 1 class + gov fee
Eritrea
C$1,382/ 1 class + gov fee
Estonia
C$1,797/ 1 class + gov fee
Eswatini
C$1,797/ 1 class + gov fee
Fiji
C$1,244/ 1 class + gov fee
Finland
C$967/ 1 class + gov fee
Gabon
C$1,106/ 1 class + gov fee
Gambia
C$1,244/ 1 class + gov fee
Georgia
C$1,106/ 1 class + gov fee
Ghana
C$1,382/ 1 class + gov fee
Grenada
C$1,797/ 1 class + gov fee
Guinea
C$1,106/ 1 class + gov fee
Guinea-Bissau
C$1,106/ 1 class + gov fee
Guyana
C$1,797/ 1 class + gov fee
Iceland
C$1,797/ 1 class + gov fee
Ireland
C$1,244/ 1 class + gov fee
Jamaica
C$1,659/ 1 class + gov fee
Kiribati
C$1,382/ 1 class + gov fee
Kosovo
C$1,244/ 1 class + gov fee
Kyrgyzstan
C$1,244/ 1 class + gov fee
Latvia
C$967/ 1 class + gov fee
Liberia
C$1,382/ 1 class + gov fee
Liechtenstein
C$1,382/ 1 class + gov fee
Lithuania
C$967/ 1 class + gov fee
Luxembourg
C$1,382/ 1 class + gov fee
Madagascar
C$1,382/ 1 class + gov fee
Mali
C$1,106/ 1 class + gov fee
Malta
C$829/ 1 class + gov fee
Marshall Islands
C$1,382/ 1 class + gov fee
Mauritania
C$1,106/ 1 class + gov fee
Mauritius
C$1,382/ 1 class + gov fee
Micronesia
C$1,382/ 1 class + gov fee
Moldova
C$1,382/ 1 class + gov fee
Monaco
C$1,936/ 1 class + gov fee
Mongolia
C$829/ 1 class + gov fee
Montenegro
C$1,244/ 1 class + gov fee
Nauru
C$1,382/ 1 class + gov fee
Netherlands
C$1,382/ 1 class + gov fee
Niger
C$1,106/ 1 class + gov fee
Nigeria
C$552/ 1 class + gov fee
North Macedonia
C$1,244/ 1 class + gov fee
Palau
C$1,382/ 1 class + gov fee
Palestine
C$1,382/ 1 class + gov fee
Papua New Guinea
C$1,106/ 1 class + gov fee
Rwanda
C$1,382/ 1 class + gov fee
Saint Kitts and Nevis
C$1,797/ 1 class + gov fee
Saint Lucia
C$1,797/ 1 class + gov fee
Saint Vincent and the Grenadines
C$1,797/ 1 class + gov fee
Samoa
C$1,659/ 1 class + gov fee
San Marino
C$1,382/ 1 class + gov fee
Sao Tome and Principe
C$1,382/ 1 class + gov fee
Senegal
C$1,106/ 1 class + gov fee
Seychelles
C$1,382/ 1 class + gov fee
Sierra Leone
C$1,382/ 1 class + gov fee
Slovenia
C$1,244/ 1 class + gov fee
Solomon Islands
C$1,382/ 1 class + gov fee
Somalia
C$1,382/ 1 class + gov fee
South Sudan
C$1,382/ 1 class + gov fee
Suriname
C$2,212/ 1 class + gov fee
Tajikistan
C$1,106/ 1 class + gov fee
Tanzania
C$967/ 1 class + gov fee
Timor-Leste
C$1,382/ 1 class + gov fee
Togo
C$1,106/ 1 class + gov fee
Tonga
C$1,797/ 1 class + gov fee
Trinidad and Tobago
C$1,659/ 1 class + gov fee
Turkmenistan
C$1,106/ 1 class + gov fee
Tuvalu
C$1,382/ 1 class + gov fee
Uzbekistan
C$967/ 1 class + gov fee
Vanuatu
C$1,659/ 1 class + gov fee
Zambia
C$1,244/ 1 class + gov fee
Zimbabwe
C$1,244/ 1 class + gov fee
OAPI
C$1,244/ 1 class + gov fee
ARIPO
C$1,382/ 1 class + gov fee